Acorda Therapeutics Inc PEG
¿Qué es el PEG de Acorda Therapeutics Inc?
El PEG de Acorda Therapeutics Inc es N/A
¿Cuál es la definición de PEG?
La relación precio/ganancias al crecimiento (PEG) es la relación P / E de una acción dividida por una tasa de crecimiento prevista de sus ganancias durante un período de 5 años.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG de compañías en Sector Health Care en NASDAQ en comparadas con Acorda Therapeutics Inc
¿Qué hace Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Empresas con peg similar a Acorda Therapeutics Inc
- Mallinckrodt Plc tiene PEG de N/A
- HighPoint Resources Corp tiene PEG de N/A
- Adamas Pharmaceuticals Inc tiene PEG de N/A
- Pivot Technology Solutions tiene PEG de N/A
- Copper Mountain Mining tiene PEG de N/A
- SITO Mobile tiene PEG de N/A
- Acorda Therapeutics Inc tiene PEG de N/A
- RumbleON Inc tiene PEG de N/A
- Endologix tiene PEG de N/A
- Alto Ingredients Inc tiene PEG de N/A
- Sunesis Pharmaceuticals Inc tiene PEG de N/A
- Unit tiene PEG de N/A
- Pacific Drilling SA tiene PEG de N/A